SlideShare a Scribd company logo
1 of 44
Download to read offline
Acute Myocardial infarction
Priya .M. Vincent & Padma Susan Mathew
ICCU
Definition
• Necrosis to cardiac muscle
due to acute occlusion of
coronary artery as a result
of plaque rupture and
thrombosis
Coronary Atherosclerosis with Thrombus
Riskfactors
• Non-modifiable
– Age
– Race
– Sex
– Heredity
• Modifiable
– Smoking
– Hypertension
– Diabetes mellitus
– Hyperlipidemia.
– Obesity
– Response to stress
Understanding Myocardial Infarction
Change in the condition of plaque in the
coronary artery
Activation of platelets
Formation of thrombus
Ischemia of tissue in the region
supplied by the artery
Coronary blood supply
< demand
Myocardial cell death
Contractility
Stimulation of the
sympathetic nervous system
Altered
repolarization of
myocardium
Release of lysosomal
enzymes
Anaerobic
Glycolysis
Myocardial
irritability
Dysrhythmia
s
ST seg.
q wave
CPK-MB
LDH
Lactic Acid
production
Angina
Contractility
Stimulation of the
sympathetic nervous system LV function
Preload Cardiac
Output
CVP
PCWP
LVEF
HR O2 NEED After load
Vasoco
nstricti
on
Continuation….
Normal Myocardium:
Myocardial Infarction - Gross
Myocardial Infarction – 1st
week
Post-infarcted Myocardium- CS
2nd
week- Myocardial Infarction -
3d
MI 18-24 hours loss of nucleus,
contraction bands, coagulative necrosis
MI 3-4 days – Hemorrhage, inflammation
MI 1st
– 2nd
week– Granulation tissue
MI 2-
4 weeks - Resorption, fibrosis
MI > 4–6 weeks - Collagen Scar
Clinical features
Symptoms:
• Prolonged chest pain
• Profuse sweating
• Nausea & vomiting
• Breathlessness
• Anxiety
• Collapse / Syncope
Acute mi
Physical signs
• Pallor, sweating, vomiting
• Tachycardia / Bradycardia
• Hypotension, oliguria, cold periphery
• Narrow pulse pressure
• Raised JVP in RVMI
• Lung crepitation
• 3rd
and 4th
heart sounds
• Fever
Diagnostic measures
• ECG
• Lab Investigations
– Troponin I
– Troponin T
– CPK-MB
– CPK [Total]
– SGOT
– CBC & ESR
• X-Ray Chest
• Echocardiogram
• Radioisotope studies
- Stress Thallium
- Rest Thallium
- Multi-gated acquisition scan [MUGA]
• Coronary Angiogram
• MRI
ECG Patterns
Coronary
Arteries
•Left Coronary A.
•L.A.Descending
•Left Circumflex
•Right Coronary A.
LCx
LAD
Area of myocardium
involved
Coronary artery supply Leads
Anterior Left coronary artery left anterior
descending branch
V2,V3,V4
Posterior Right Coronary Artery V1 – V3
Inferior Right Coronary Artery II, III, avf
Anteroseptel Left Coronary Artery left anterior
descending branch
V2 & V3
High lateral Circumflex artery, marginal branch or
LCA
I, aVL
Apical Usually LCA, left anterior branch may
be RCA, posterior descending
branch
V5 & V6
Enzyme Normal value Onset Peak Return to
normal
Trop. I &
Trop T
<0.2 4-6hrs 24-36 hrs. 10-12days
CPK[Total] 21-232 hrs. 12-24 hrs. 3-5days
CPK– MB <25 . 12-20 hrs. 42-48hrs.
SGOT <40 6-12hrs. 24-48 hrs. ≥10days
LDH 160 – 410 24hrs. 48-72 hrs. 7-10days
Management
• Se e k im m e diate m e dicalatte ntio n
Medical Management
• Major goals:
– Management of the acute attack
– Prevention of complications
– Rehabilitation
1. Management of Acute attack
• History
• ECG
• IV access
• Routine blood investigations
• Continuous cardiac monitoring
• Invasive monitoring
General Measures
• Pain control
• Aspirin
• Clopidogrel
• Nitrates
• Beta-adrenoreceptor blockers
• ACE inhibitors
• Bed rest upto 48 hours
• Soft diet
• Stool softeners
Patients with ischemic type discomfort
ECG
ST elevation ECG strongly suspicious for
ischemia ( ST depression, T
wave inversion
Non diagnostic ECG
Eligible for
thrombolytic
therapy
Thrombolytic
therapy
contraindicated
Admit
Initial antiischemic
therapy or treat as
unstable angina
Thrombolytic
therapy
Primary PTCA
Continue
evaluation
Obtain follow up
serum cardiac
marker levels
ECHO
Evidence of
ischemic infarction
Evidence of
ischemic infarctionYes
NoInitial reperfusion strategy if ST
elevation develops Discharge
Thrombolysis
• Streptokinase
• Urokinase
• Tissue plasminogen activator (t-PA)
• Acylated plasminogen
streptokinase activator complex
(APSAC)
Criteria forthrombolysis in acute
MI
Indications:
• Chest pain
• ECG changes
• Time from onset of symptoms
<6 hrs. : most beneficial
6-12 hrs. : lesser but still important benefits
>12 hrs. : diminishing benefits but may still
be used in selected patients
Absolute contraindications
1. Active internal bleeding (excluding menses)
2. Suspected aortic dissection
3. Recent head trauma or known intracranial
neoplasm
4. Hemorrhagic CVA
5. Major surgery or trauma < 2weeks.
Relative contraindications
• BP>180/110mmHg on at least 2 readings
• History of hypertension
• Active peptic ulcer
• History of CVA
• Current use of anticoagulants
• Prolonged or traumatic CPR
• Diabetic hemorrhagic retinopathy
• Pregnancy
• Prior exposure to STK & APSAC
Protocol followed in ICCU
• Aspirin 150-325mg chewed, 75mg daily thereafter
• Clopidogrel 300mg stat & 75mg daily
• Pain relief
– Inj. Morphine 3mg + Inj. Phenergan 12.5mg slow IV
– Inj. Pethedine 12.5mg IV in patients with asthma
• O2 2-4 lit/min for 2-3 hrs. If saturation <95% continue
beyond 3hours.
• 2 IV access if the patient is for thrombolysis
• Inj.Avil 2cc + Inj. Hydrocortisone 200mg+Inj. Ranitidine
50mg IV
• Inj.Streptokinase 1.5million /15 lakhs units in 100ml NS over
1hr.
• Inj. Heparin 60 units/kg bolus + 12units/kg/hr.infusion 4 hrs.
after STK
• Inj. NTG infusion x 24-48hrs. in LVF, large anti. MI
persistent pain
• β blockers to all patients unless contraindicated
Metoprolol 12.5mg – 25mg BD
use carvedilol 3.125mg OD for anti. MI, LVF, previous MI
• Statins if LDL >100mg/dL & TGL>150mg/dL
• Stool softeners
• Hypnotic – Lorazepam 1-2mg HS
• NPO till pain relief
Liquid diet x 12 hours.
Semisolid diet thereafter, low fat,low cholesterol 1500
calories diet.
• Pulse,BP ½ hourly till stable then hourly.
• ECG 90 min,180 min after starting STK &daily thereafter till
transfer out.
• Consider IV beta-blockers in young patients with
tachycardia,hypertension(Metoprolol 5mg 3 doses at 5min
interval.
2. Prevention of complications
a. Dysrhythmias
b. Cardiogenic shock
c. Heart failure & pulmonary edema
d. Pulmonary embolism
e. Recurrent MI
f. Complications due to necrosis of myocardium
g. Pericarditis
h. Dressler’s syndrome (late pericarditis)
3. Rehabilitation
Overall goals
• Lead a productive life
• Remain within the limits of the heart’s ability to respond to
increase in activity and stress
Sub goals
• A programme of progressive physical activity
• Health teaching
• Help to accept the limitations
• Aid the client in adjusting to changes in occupational goal
• Change the psychological factors
• Reduce risk factors
Phase I (in hospital)
• Bed rest for 1 day with liquid diet
• When vital signs get stabilized, patient can move in bed
• Passive exercises
• As strength is regained - sit on the side of the bed and
dangle the feet.
• Once transferred from CCU self-care activities are
encouraged
• Brief walks with supervision
• Instruct regarding warning signs of over exertion
• Client education
Phase II (Intermediate)
• If no complications, discharge at the end of one week
• Sexual intercourse after 4-8 weeks.
• Stop smoking completely
• Encourage frequent walks
• Avoid strenuous activities
• Monitored group programmes
• Warm up and stretching exercises
• Aspirin daily.
• Return to work at the end of 8-9 wks.
• Follow up in hospital between 8-9 wks.
Phase – III (Long term)
• Periodic evaluation
Interventional Management
[PTCA] Percutaneous Transluminal Coronary Angioplasty
Coronary Artery Bypass Graft
Surgery [CABG]
Nursing Management
• Nursing Diagnosis:
– Acute chest pain related to myocardial ischemia resulting from coronary
artery occlusion with loss/restriction of blood flow to an area of
myocardium and necrosis of the myocardium.
– Dysrhythmias related to electrical instability or irritability secondary to
ischemic or infracted tissue.
– Decreased cardiac output related to negative inotropic changes in the
heart secondary to myocardial ischemia, injury or infarction.
– Impaired gas exchange related to decreased cardiac output
– Powerlessness related to hospital environment and anticipated life style
changes
– Fear & anxiety related to hospital admission and fear of death
– Altered health maintenance related to MI and implications for life style
changes.
Thankyou

More Related Content

What's hot (20)

Tachyarrhythmias
TachyarrhythmiasTachyarrhythmias
Tachyarrhythmias
 
Supraventricular tachycardias
Supraventricular tachycardiasSupraventricular tachycardias
Supraventricular tachycardias
 
Atrial fibrillation
Atrial  fibrillation Atrial  fibrillation
Atrial fibrillation
 
ECG: Ventricular Premature Beats
ECG: Ventricular Premature BeatsECG: Ventricular Premature Beats
ECG: Ventricular Premature Beats
 
Hypertension
HypertensionHypertension
Hypertension
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Brady arryhthmias
Brady arryhthmiasBrady arryhthmias
Brady arryhthmias
 
Management of Cardiogenic shock
Management of Cardiogenic shockManagement of Cardiogenic shock
Management of Cardiogenic shock
 
Ventricular arrhythmias
Ventricular arrhythmiasVentricular arrhythmias
Ventricular arrhythmias
 
Avrt vz vt
Avrt vz vtAvrt vz vt
Avrt vz vt
 
Atrial fibrillation
Atrial fibrillation Atrial fibrillation
Atrial fibrillation
 
SUPRAVENTRICULAR TACHYCARDIA - SVT
SUPRAVENTRICULAR TACHYCARDIA - SVTSUPRAVENTRICULAR TACHYCARDIA - SVT
SUPRAVENTRICULAR TACHYCARDIA - SVT
 
PSVT
PSVTPSVT
PSVT
 
Approach to bradyarrythmias1
Approach to bradyarrythmias1Approach to bradyarrythmias1
Approach to bradyarrythmias1
 
Cardiac arrythmias
Cardiac arrythmiasCardiac arrythmias
Cardiac arrythmias
 
Tachyarrhythmia
TachyarrhythmiaTachyarrhythmia
Tachyarrhythmia
 
Arrythmias in ICCU
Arrythmias in ICCUArrythmias in ICCU
Arrythmias in ICCU
 
Narrow QRS Tachycardia
Narrow QRS TachycardiaNarrow QRS Tachycardia
Narrow QRS Tachycardia
 
Atrial fib & flutter
Atrial fib & flutterAtrial fib & flutter
Atrial fib & flutter
 
Tachyarrhythmias
TachyarrhythmiasTachyarrhythmias
Tachyarrhythmias
 

Similar to Acute mi

Bleeding disorders.pdf
Bleeding disorders.pdfBleeding disorders.pdf
Bleeding disorders.pdfUVAS
 
Presentation on mi
Presentation on miPresentation on mi
Presentation on milaxmirani
 
Myocardial infraction sushila
Myocardial infraction sushilaMyocardial infraction sushila
Myocardial infraction sushilaSushilaHamal
 
Myocardial infraction sushila
Myocardial infraction sushilaMyocardial infraction sushila
Myocardial infraction sushilaSushilaHamal
 
final CAD ggggg.pptx
final CAD ggggg.pptxfinal CAD ggggg.pptx
final CAD ggggg.pptxNaveesha4
 
cardiac care after angiogram
cardiac care after angiogramcardiac care after angiogram
cardiac care after angiogramfysal faruq
 
Consultations in cardiology
Consultations in cardiologyConsultations in cardiology
Consultations in cardiologyVijay Yadav
 
Supportive treatment in stroke
Supportive treatment in strokeSupportive treatment in stroke
Supportive treatment in strokeNeurologyKota
 
Atlas myocardialinfarction
Atlas myocardialinfarctionAtlas myocardialinfarction
Atlas myocardialinfarctionHIRANGER
 
Hypertension in anesthesia1
Hypertension in anesthesia1Hypertension in anesthesia1
Hypertension in anesthesia1Harith Daggupati
 
St elevation myocardial infarction
St elevation myocardial infarctionSt elevation myocardial infarction
St elevation myocardial infarctionsalaheldin abusin
 
preoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptxpreoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptxGokul Krishnan
 
Preoperative prepration of the patients before surgery
Preoperative prepration of the patients before surgery Preoperative prepration of the patients before surgery
Preoperative prepration of the patients before surgery nikhilameerchetty
 
Contrast Induce Nephropathy
Contrast Induce NephropathyContrast Induce Nephropathy
Contrast Induce NephropathyZiyad Salih
 
Acute coronary syndrome NSTEMI
Acute coronary syndrome NSTEMIAcute coronary syndrome NSTEMI
Acute coronary syndrome NSTEMIJackie San
 

Similar to Acute mi (20)

Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Bleeding disorders.pdf
Bleeding disorders.pdfBleeding disorders.pdf
Bleeding disorders.pdf
 
Presentation on mi
Presentation on miPresentation on mi
Presentation on mi
 
Stroke management
Stroke managementStroke management
Stroke management
 
Myocardial infraction sushila
Myocardial infraction sushilaMyocardial infraction sushila
Myocardial infraction sushila
 
Myocardial infraction sushila
Myocardial infraction sushilaMyocardial infraction sushila
Myocardial infraction sushila
 
final CAD ggggg.pptx
final CAD ggggg.pptxfinal CAD ggggg.pptx
final CAD ggggg.pptx
 
cardiac care after angiogram
cardiac care after angiogramcardiac care after angiogram
cardiac care after angiogram
 
Consultations in cardiology
Consultations in cardiologyConsultations in cardiology
Consultations in cardiology
 
Supportive treatment in stroke
Supportive treatment in strokeSupportive treatment in stroke
Supportive treatment in stroke
 
Atlas myocardialinfarction
Atlas myocardialinfarctionAtlas myocardialinfarction
Atlas myocardialinfarction
 
Hypertension in anesthesia1
Hypertension in anesthesia1Hypertension in anesthesia1
Hypertension in anesthesia1
 
CAD 2014 - NSTE ACS
CAD 2014 - NSTE ACS CAD 2014 - NSTE ACS
CAD 2014 - NSTE ACS
 
St elevation myocardial infarction
St elevation myocardial infarctionSt elevation myocardial infarction
St elevation myocardial infarction
 
preoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptxpreoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptx
 
Addison disease by dr shahjada selim
Addison disease by dr shahjada selimAddison disease by dr shahjada selim
Addison disease by dr shahjada selim
 
Emergencies in oncology
Emergencies in oncologyEmergencies in oncology
Emergencies in oncology
 
Preoperative prepration of the patients before surgery
Preoperative prepration of the patients before surgery Preoperative prepration of the patients before surgery
Preoperative prepration of the patients before surgery
 
Contrast Induce Nephropathy
Contrast Induce NephropathyContrast Induce Nephropathy
Contrast Induce Nephropathy
 
Acute coronary syndrome NSTEMI
Acute coronary syndrome NSTEMIAcute coronary syndrome NSTEMI
Acute coronary syndrome NSTEMI
 

More from Chandan N

Universal & transmission precaution
Universal & transmission precautionUniversal & transmission precaution
Universal & transmission precautionChandan N
 
Coronory angiography
Coronory angiographyCoronory angiography
Coronory angiographyChandan N
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpbChandan N
 
Reducing stroke in AF
Reducing stroke in AFReducing stroke in AF
Reducing stroke in AFChandan N
 
Antiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisAntiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisChandan N
 
Anticoagulant in DVT and APE
Anticoagulant in DVT and APEAnticoagulant in DVT and APE
Anticoagulant in DVT and APEChandan N
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse Chandan N
 
Renal failure
Renal failureRenal failure
Renal failureChandan N
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphomaChandan N
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphomaChandan N
 
Final housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureFinal housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureChandan N
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancyChandan N
 
Control and prevention_of_influenza
Control and prevention_of_influenzaControl and prevention_of_influenza
Control and prevention_of_influenzaChandan N
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failureChandan N
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatmentChandan N
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failureChandan N
 
Abnormal puerperium
Abnormal puerperiumAbnormal puerperium
Abnormal puerperiumChandan N
 

More from Chandan N (20)

Universal & transmission precaution
Universal & transmission precautionUniversal & transmission precaution
Universal & transmission precaution
 
Coronory angiography
Coronory angiographyCoronory angiography
Coronory angiography
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpb
 
Reducing stroke in AF
Reducing stroke in AFReducing stroke in AF
Reducing stroke in AF
 
Antiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisAntiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosis
 
Anticoagulant in DVT and APE
Anticoagulant in DVT and APEAnticoagulant in DVT and APE
Anticoagulant in DVT and APE
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse
 
Renal failure
Renal failureRenal failure
Renal failure
 
Nutrition
NutritionNutrition
Nutrition
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphoma
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphoma
 
ckd
ckdckd
ckd
 
Nhl
NhlNhl
Nhl
 
Final housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureFinal housestaff opportunistic infections lecture
Final housestaff opportunistic infections lecture
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
Control and prevention_of_influenza
Control and prevention_of_influenzaControl and prevention_of_influenza
Control and prevention_of_influenza
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failure
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatment
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Abnormal puerperium
Abnormal puerperiumAbnormal puerperium
Abnormal puerperium
 

Recently uploaded

EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfMayuriGamit2
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxRajendra Dev Bhatt
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxSizan Thapa
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxsiddharthroy26587
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfHongBiThi1
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxSizan Thapa
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdfHongBiThi1
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedSBL DIGITAL
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 

Recently uploaded (20)

EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptx
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptxANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
ANATOMY OF THE CEREBRUM WITH CLINICAL ANATOMY.pptx
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
 
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptxNECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
NECROSIS FOR MBBS FIRST YEAR STUDENTS MADE EASY.pptx
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limited
 
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 

Acute mi

  • 1. Acute Myocardial infarction Priya .M. Vincent & Padma Susan Mathew ICCU
  • 2. Definition • Necrosis to cardiac muscle due to acute occlusion of coronary artery as a result of plaque rupture and thrombosis
  • 4. Riskfactors • Non-modifiable – Age – Race – Sex – Heredity • Modifiable – Smoking – Hypertension – Diabetes mellitus – Hyperlipidemia. – Obesity – Response to stress
  • 5. Understanding Myocardial Infarction Change in the condition of plaque in the coronary artery Activation of platelets Formation of thrombus Ischemia of tissue in the region supplied by the artery Coronary blood supply < demand Myocardial cell death Contractility Stimulation of the sympathetic nervous system Altered repolarization of myocardium Release of lysosomal enzymes Anaerobic Glycolysis Myocardial irritability Dysrhythmia s ST seg. q wave CPK-MB LDH Lactic Acid production Angina
  • 6. Contractility Stimulation of the sympathetic nervous system LV function Preload Cardiac Output CVP PCWP LVEF HR O2 NEED After load Vasoco nstricti on Continuation….
  • 12. MI 18-24 hours loss of nucleus, contraction bands, coagulative necrosis
  • 13. MI 3-4 days – Hemorrhage, inflammation
  • 14. MI 1st – 2nd week– Granulation tissue
  • 15. MI 2- 4 weeks - Resorption, fibrosis
  • 16. MI > 4–6 weeks - Collagen Scar
  • 17. Clinical features Symptoms: • Prolonged chest pain • Profuse sweating • Nausea & vomiting • Breathlessness • Anxiety • Collapse / Syncope
  • 19. Physical signs • Pallor, sweating, vomiting • Tachycardia / Bradycardia • Hypotension, oliguria, cold periphery • Narrow pulse pressure • Raised JVP in RVMI • Lung crepitation • 3rd and 4th heart sounds • Fever
  • 20. Diagnostic measures • ECG • Lab Investigations – Troponin I – Troponin T – CPK-MB – CPK [Total] – SGOT – CBC & ESR • X-Ray Chest • Echocardiogram • Radioisotope studies - Stress Thallium - Rest Thallium - Multi-gated acquisition scan [MUGA] • Coronary Angiogram • MRI
  • 22. Coronary Arteries •Left Coronary A. •L.A.Descending •Left Circumflex •Right Coronary A. LCx LAD
  • 23. Area of myocardium involved Coronary artery supply Leads Anterior Left coronary artery left anterior descending branch V2,V3,V4 Posterior Right Coronary Artery V1 – V3 Inferior Right Coronary Artery II, III, avf Anteroseptel Left Coronary Artery left anterior descending branch V2 & V3 High lateral Circumflex artery, marginal branch or LCA I, aVL Apical Usually LCA, left anterior branch may be RCA, posterior descending branch V5 & V6
  • 24. Enzyme Normal value Onset Peak Return to normal Trop. I & Trop T <0.2 4-6hrs 24-36 hrs. 10-12days CPK[Total] 21-232 hrs. 12-24 hrs. 3-5days CPK– MB <25 . 12-20 hrs. 42-48hrs. SGOT <40 6-12hrs. 24-48 hrs. ≥10days LDH 160 – 410 24hrs. 48-72 hrs. 7-10days
  • 25. Management • Se e k im m e diate m e dicalatte ntio n
  • 26. Medical Management • Major goals: – Management of the acute attack – Prevention of complications – Rehabilitation
  • 27. 1. Management of Acute attack • History • ECG • IV access • Routine blood investigations • Continuous cardiac monitoring • Invasive monitoring
  • 28. General Measures • Pain control • Aspirin • Clopidogrel • Nitrates • Beta-adrenoreceptor blockers • ACE inhibitors • Bed rest upto 48 hours • Soft diet • Stool softeners
  • 29. Patients with ischemic type discomfort ECG ST elevation ECG strongly suspicious for ischemia ( ST depression, T wave inversion Non diagnostic ECG Eligible for thrombolytic therapy Thrombolytic therapy contraindicated Admit Initial antiischemic therapy or treat as unstable angina Thrombolytic therapy Primary PTCA Continue evaluation Obtain follow up serum cardiac marker levels ECHO Evidence of ischemic infarction Evidence of ischemic infarctionYes NoInitial reperfusion strategy if ST elevation develops Discharge
  • 30. Thrombolysis • Streptokinase • Urokinase • Tissue plasminogen activator (t-PA) • Acylated plasminogen streptokinase activator complex (APSAC)
  • 31. Criteria forthrombolysis in acute MI Indications: • Chest pain • ECG changes • Time from onset of symptoms <6 hrs. : most beneficial 6-12 hrs. : lesser but still important benefits >12 hrs. : diminishing benefits but may still be used in selected patients
  • 32. Absolute contraindications 1. Active internal bleeding (excluding menses) 2. Suspected aortic dissection 3. Recent head trauma or known intracranial neoplasm 4. Hemorrhagic CVA 5. Major surgery or trauma < 2weeks.
  • 33. Relative contraindications • BP>180/110mmHg on at least 2 readings • History of hypertension • Active peptic ulcer • History of CVA • Current use of anticoagulants • Prolonged or traumatic CPR • Diabetic hemorrhagic retinopathy • Pregnancy • Prior exposure to STK & APSAC
  • 34. Protocol followed in ICCU • Aspirin 150-325mg chewed, 75mg daily thereafter • Clopidogrel 300mg stat & 75mg daily • Pain relief – Inj. Morphine 3mg + Inj. Phenergan 12.5mg slow IV – Inj. Pethedine 12.5mg IV in patients with asthma • O2 2-4 lit/min for 2-3 hrs. If saturation <95% continue beyond 3hours. • 2 IV access if the patient is for thrombolysis • Inj.Avil 2cc + Inj. Hydrocortisone 200mg+Inj. Ranitidine 50mg IV • Inj.Streptokinase 1.5million /15 lakhs units in 100ml NS over 1hr. • Inj. Heparin 60 units/kg bolus + 12units/kg/hr.infusion 4 hrs. after STK
  • 35. • Inj. NTG infusion x 24-48hrs. in LVF, large anti. MI persistent pain • β blockers to all patients unless contraindicated Metoprolol 12.5mg – 25mg BD use carvedilol 3.125mg OD for anti. MI, LVF, previous MI • Statins if LDL >100mg/dL & TGL>150mg/dL • Stool softeners • Hypnotic – Lorazepam 1-2mg HS • NPO till pain relief Liquid diet x 12 hours. Semisolid diet thereafter, low fat,low cholesterol 1500 calories diet. • Pulse,BP ½ hourly till stable then hourly. • ECG 90 min,180 min after starting STK &daily thereafter till transfer out. • Consider IV beta-blockers in young patients with tachycardia,hypertension(Metoprolol 5mg 3 doses at 5min interval.
  • 36. 2. Prevention of complications a. Dysrhythmias b. Cardiogenic shock c. Heart failure & pulmonary edema d. Pulmonary embolism e. Recurrent MI f. Complications due to necrosis of myocardium g. Pericarditis h. Dressler’s syndrome (late pericarditis)
  • 37. 3. Rehabilitation Overall goals • Lead a productive life • Remain within the limits of the heart’s ability to respond to increase in activity and stress Sub goals • A programme of progressive physical activity • Health teaching • Help to accept the limitations • Aid the client in adjusting to changes in occupational goal • Change the psychological factors • Reduce risk factors
  • 38. Phase I (in hospital) • Bed rest for 1 day with liquid diet • When vital signs get stabilized, patient can move in bed • Passive exercises • As strength is regained - sit on the side of the bed and dangle the feet. • Once transferred from CCU self-care activities are encouraged • Brief walks with supervision • Instruct regarding warning signs of over exertion • Client education
  • 39. Phase II (Intermediate) • If no complications, discharge at the end of one week • Sexual intercourse after 4-8 weeks. • Stop smoking completely • Encourage frequent walks • Avoid strenuous activities • Monitored group programmes • Warm up and stretching exercises • Aspirin daily. • Return to work at the end of 8-9 wks. • Follow up in hospital between 8-9 wks.
  • 40. Phase – III (Long term) • Periodic evaluation
  • 41. Interventional Management [PTCA] Percutaneous Transluminal Coronary Angioplasty
  • 42. Coronary Artery Bypass Graft Surgery [CABG]
  • 43. Nursing Management • Nursing Diagnosis: – Acute chest pain related to myocardial ischemia resulting from coronary artery occlusion with loss/restriction of blood flow to an area of myocardium and necrosis of the myocardium. – Dysrhythmias related to electrical instability or irritability secondary to ischemic or infracted tissue. – Decreased cardiac output related to negative inotropic changes in the heart secondary to myocardial ischemia, injury or infarction. – Impaired gas exchange related to decreased cardiac output – Powerlessness related to hospital environment and anticipated life style changes – Fear & anxiety related to hospital admission and fear of death – Altered health maintenance related to MI and implications for life style changes.